首页> 美国卫生研究院文献>The Journal of Clinical Investigation >The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease
【2h】

The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease

机译:小鼠胸腺移植物抗宿主疾病需要溶细胞分子Fas配体和TRAIL

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Thymic graft-versus-host disease (tGVHD) can contribute to profound T cell deficiency and repertoire restriction after allogeneic BM transplantation (allo-BMT). However, the cellular mechanisms of tGVHD and interactions between donor alloreactive T cells and thymic tissues remain poorly defined. Using clinically relevant murine allo-BMT models, we show here that even minimal numbers of donor alloreactive T cells, which caused mild nonlethal systemic graft-versus-host disease, were sufficient to damage the thymus, delay T lineage reconstitution, and compromise donor peripheral T cell function. Furthermore, to mediate tGVHD, donor alloreactive T cells required trafficking molecules, including CCR9, L selectin, P selectin glycoprotein ligand-1, the integrin subunits αE and β7, CCR2, and CXCR3, and costimulatory/inhibitory molecules, including Ox40 and carcinoembryonic antigen-associated cell adhesion molecule 1. We found that radiation in BMT conditioning regimens upregulated expression of the death receptors Fas and death receptor 5 (DR5) on thymic stromal cells (especially epithelium), while decreasing expression of the antiapoptotic regulator cellular caspase-8–like inhibitory protein. Donor alloreactive T cells used the cognate proteins FasL and TNF-related apoptosis-inducing ligand (TRAIL) (but not TNF or perforin) to mediate tGVHD, thereby damaging thymic stromal cells, cytoarchitecture, and function. Strategies that interfere with Fas/FasL and TRAIL/DR5 interactions may therefore represent a means to attenuate tGVHD and improve T cell reconstitution in allo-BMT recipients.
机译:异基因BM移植(allo-BMT)后,胸腺移植物抗宿主病(tGVHD)可能导致严重的T细胞缺乏和库限制。但是,tGVHD的细胞机制以及供体同种异体反应性T细胞和胸腺组织之间的相互作用仍然不清楚。使用临床相关的鼠异源-BMT模型,我们在这里显示,即使是极少量的供体同种异体反应性T细胞,其引起轻度非致死性全身性移植物抗宿主病,也足以损害胸腺,延缓T谱系重建并损害供体外周血T细胞功能。此外,为了介导tGVHD,供体的同种异体反应性T细胞需要运输分子,包括CCR9,L选择素,P选择素糖蛋白配体-1,整联蛋白亚基αE和β7,CCR2和CXCR3,以及共刺激/抑制分子,包括Ox40和癌胚抗原相关的细胞粘附分子1.我们发现BMT调理方案中的辐射可上调胸腺基质细胞(尤其是上皮细胞)上的死亡受体Fas和死亡受体5(DR5)的表达,同时降低抗凋亡调节剂细胞caspase-8的表达。像抑制蛋白。供体的同种异体反应性T细胞使用相关蛋白FasL和TNF相关的凋亡诱导配体(TRAIL)(而不是TNF或穿孔素)介导tGVHD,从而破坏胸腺基质细胞,细胞结构和功能。因此,干扰Fas / FasL和TRAIL / DR5相互作用的策略可能代表一种减弱tGVHD并改善同种BMT受体中T细胞重构的手段。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号